Global In Vitro Drug Release Testing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08254300

Publication Date:

August 6, 2025

Pages:

134

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

According to this study, the global In Vitro Drug Release Testing market size will reach US$ 166 million by 2031.
In Vitro Drug Release Testing is an experimental method used to evaluate the rate and extent of drug release from a pharmaceutical formulation over a specified period of time. This test is commonly used to evaluate the release properties of topical treatments (e.g., topical applications, gels, lotions, etc.).
The In Vitro Drug Release Testing market is evolving rapidly, driven by the growing emphasis on quality control, regulatory compliance, and the need for predictive drug performance data in pharmaceutical development. This testing plays a critical role in evaluating the release characteristics of drug formulations, providing essential insights into product behavior before clinical use. As the pharmaceutical industry expands its focus on complex generics, novel drug delivery systems, and biosimilars, demand for precise and reproducible in vitro testing methods continues to rise. Technological advancements in dissolution testing equipment, automation, and analytical techniques are enhancing the accuracy and efficiency of testing processes. Additionally, regulatory bodies are placing increased importance on in vitro release data, reinforcing its role in supporting formulation optimization and ensuring consistent therapeutic outcomes.
The 鈥淚n Vitro Drug Release Testing Industry Forecast鈥� looks at past sales and reviews total world In Vitro Drug Release Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro Drug Release Testing sales for 2025 through 2031. With In Vitro Drug Release Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Drug Release Testing industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Drug Release Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Drug Release Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global In Vitro Drug Release Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Drug Release Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Drug Release Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Drug Release Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Formulation Optimization
Quality Control
Generic Drug Approval
Others
Segmentation by Application:
Creams
Ointments
Gels
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
QPS
Recipharm
CPL
MedPharm
Nuvisan
Diteba
Eurofins
Raptim Research
The J. Molner Company
Medicilon
Porton
Joanneum Research
Frontage
CD Formulation
Stira Pharmaceuticals
BioLInk LIfe Sciences
Sun-Novo

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In Vitro Drug Release Testing Market Size (2020-2031)
2.1.2 In Vitro Drug Release Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for In Vitro Drug Release Testing by Country/Region (2020, 2024 & 2031)
2.2 In Vitro Drug Release Testing Segment by Type
2.2.1 Formulation Optimization
2.2.2 Quality Control
2.2.3 Generic Drug Approval
2.2.4 Others
2.3 In Vitro Drug Release Testing Market Size by Type
2.3.1 In Vitro Drug Release Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global In Vitro Drug Release Testing Market Size Market Share by Type (2020-2025)
2.4 In Vitro Drug Release Testing Segment by Application
2.4.1 Creams
2.4.2 Ointments
2.4.3 Gels
2.4.4 Others
2.5 In Vitro Drug Release Testing Market Size by Application
2.5.1 In Vitro Drug Release Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global In Vitro Drug Release Testing Market Size Market Share by Application (2020-2025)
3 In Vitro Drug Release Testing Market Size by Player
3.1 In Vitro Drug Release Testing Market Size Market Share by Player
3.1.1 Global In Vitro Drug Release Testing Revenue by Player (2020-2025)
3.1.2 Global In Vitro Drug Release Testing Revenue Market Share by Player (2020-2025)
3.2 Global In Vitro Drug Release Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 In Vitro Drug Release Testing by Region
4.1 In Vitro Drug Release Testing Market Size by Region (2020-2025)
4.2 Global In Vitro Drug Release Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas In Vitro Drug Release Testing Market Size Growth (2020-2025)
4.4 APAC In Vitro Drug Release Testing Market Size Growth (2020-2025)
4.5 Europe In Vitro Drug Release Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa In Vitro Drug Release Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas In Vitro Drug Release Testing Market Size by Country (2020-2025)
5.2 Americas In Vitro Drug Release Testing Market Size by Type (2020-2025)
5.3 Americas In Vitro Drug Release Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In Vitro Drug Release Testing Market Size by Region (2020-2025)
6.2 APAC In Vitro Drug Release Testing Market Size by Type (2020-2025)
6.3 APAC In Vitro Drug Release Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In Vitro Drug Release Testing Market Size by Country (2020-2025)
7.2 Europe In Vitro Drug Release Testing Market Size by Type (2020-2025)
7.3 Europe In Vitro Drug Release Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa In Vitro Drug Release Testing by Region (2020-2025)
8.2 Middle East & Africa In Vitro Drug Release Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa In Vitro Drug Release Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global In Vitro Drug Release Testing Market Forecast
10.1 Global In Vitro Drug Release Testing Forecast by Region (2026-2031)
10.1.1 Global In Vitro Drug Release Testing Forecast by Region (2026-2031)
10.1.2 Americas In Vitro Drug Release Testing Forecast
10.1.3 APAC In Vitro Drug Release Testing Forecast
10.1.4 Europe In Vitro Drug Release Testing Forecast
10.1.5 Middle East & Africa In Vitro Drug Release Testing Forecast
10.2 Americas In Vitro Drug Release Testing Forecast by Country (2026-2031)
10.2.1 United States Market In Vitro Drug Release Testing Forecast
10.2.2 Canada Market In Vitro Drug Release Testing Forecast
10.2.3 Mexico Market In Vitro Drug Release Testing Forecast
10.2.4 Brazil Market In Vitro Drug Release Testing Forecast
10.3 APAC In Vitro Drug Release Testing Forecast by Region (2026-2031)
10.3.1 China In Vitro Drug Release Testing Market Forecast
10.3.2 Japan Market In Vitro Drug Release Testing Forecast
10.3.3 Korea Market In Vitro Drug Release Testing Forecast
10.3.4 Southeast Asia Market In Vitro Drug Release Testing Forecast
10.3.5 India Market In Vitro Drug Release Testing Forecast
10.3.6 Australia Market In Vitro Drug Release Testing Forecast
10.4 Europe In Vitro Drug Release Testing Forecast by Country (2026-2031)
10.4.1 Germany Market In Vitro Drug Release Testing Forecast
10.4.2 France Market In Vitro Drug Release Testing Forecast
10.4.3 UK Market In Vitro Drug Release Testing Forecast
10.4.4 Italy Market In Vitro Drug Release Testing Forecast
10.4.5 Russia Market In Vitro Drug Release Testing Forecast
10.5 Middle East & Africa In Vitro Drug Release Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market In Vitro Drug Release Testing Forecast
10.5.2 South Africa Market In Vitro Drug Release Testing Forecast
10.5.3 Israel Market In Vitro Drug Release Testing Forecast
10.5.4 Turkey Market In Vitro Drug Release Testing Forecast
10.6 Global In Vitro Drug Release Testing Forecast by Type (2026-2031)
10.7 Global In Vitro Drug Release Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market In Vitro Drug Release Testing Forecast
11 Key Players Analysis
11.1 QPS
11.1.1 QPS Company Information
11.1.2 QPS In Vitro Drug Release Testing Product Offered
11.1.3 QPS In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 QPS Main Business Overview
11.1.5 QPS Latest Developments
11.2 Recipharm
11.2.1 Recipharm Company Information
11.2.2 Recipharm In Vitro Drug Release Testing Product Offered
11.2.3 Recipharm In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Recipharm Main Business Overview
11.2.5 Recipharm Latest Developments
11.3 CPL
11.3.1 CPL Company Information
11.3.2 CPL In Vitro Drug Release Testing Product Offered
11.3.3 CPL In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CPL Main Business Overview
11.3.5 CPL Latest Developments
11.4 MedPharm
11.4.1 MedPharm Company Information
11.4.2 MedPharm In Vitro Drug Release Testing Product Offered
11.4.3 MedPharm In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 MedPharm Main Business Overview
11.4.5 MedPharm Latest Developments
11.5 Nuvisan
11.5.1 Nuvisan Company Information
11.5.2 Nuvisan In Vitro Drug Release Testing Product Offered
11.5.3 Nuvisan In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Nuvisan Main Business Overview
11.5.5 Nuvisan Latest Developments
11.6 Diteba
11.6.1 Diteba Company Information
11.6.2 Diteba In Vitro Drug Release Testing Product Offered
11.6.3 Diteba In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Diteba Main Business Overview
11.6.5 Diteba Latest Developments
11.7 Eurofins
11.7.1 Eurofins Company Information
11.7.2 Eurofins In Vitro Drug Release Testing Product Offered
11.7.3 Eurofins In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Eurofins Main Business Overview
11.7.5 Eurofins Latest Developments
11.8 Raptim Research
11.8.1 Raptim Research Company Information
11.8.2 Raptim Research In Vitro Drug Release Testing Product Offered
11.8.3 Raptim Research In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Raptim Research Main Business Overview
11.8.5 Raptim Research Latest Developments
11.9 The J. Molner Company
11.9.1 The J. Molner Company Company Information
11.9.2 The J. Molner Company In Vitro Drug Release Testing Product Offered
11.9.3 The J. Molner Company In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 The J. Molner Company Main Business Overview
11.9.5 The J. Molner Company Latest Developments
11.10 Medicilon
11.10.1 Medicilon Company Information
11.10.2 Medicilon In Vitro Drug Release Testing Product Offered
11.10.3 Medicilon In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Medicilon Main Business Overview
11.10.5 Medicilon Latest Developments
11.11 Porton
11.11.1 Porton Company Information
11.11.2 Porton In Vitro Drug Release Testing Product Offered
11.11.3 Porton In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Porton Main Business Overview
11.11.5 Porton Latest Developments
11.12 Joanneum Research
11.12.1 Joanneum Research Company Information
11.12.2 Joanneum Research In Vitro Drug Release Testing Product Offered
11.12.3 Joanneum Research In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Joanneum Research Main Business Overview
11.12.5 Joanneum Research Latest Developments
11.13 Frontage
11.13.1 Frontage Company Information
11.13.2 Frontage In Vitro Drug Release Testing Product Offered
11.13.3 Frontage In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Frontage Main Business Overview
11.13.5 Frontage Latest Developments
11.14 CD Formulation
11.14.1 CD Formulation Company Information
11.14.2 CD Formulation In Vitro Drug Release Testing Product Offered
11.14.3 CD Formulation In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 CD Formulation Main Business Overview
11.14.5 CD Formulation Latest Developments
11.15 Stira Pharmaceuticals
11.15.1 Stira Pharmaceuticals Company Information
11.15.2 Stira Pharmaceuticals In Vitro Drug Release Testing Product Offered
11.15.3 Stira Pharmaceuticals In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Stira Pharmaceuticals Main Business Overview
11.15.5 Stira Pharmaceuticals Latest Developments
11.16 BioLInk LIfe Sciences
11.16.1 BioLInk LIfe Sciences Company Information
11.16.2 BioLInk LIfe Sciences In Vitro Drug Release Testing Product Offered
11.16.3 BioLInk LIfe Sciences In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 BioLInk LIfe Sciences Main Business Overview
11.16.5 BioLInk LIfe Sciences Latest Developments
11.17 Sun-Novo
11.17.1 Sun-Novo Company Information
11.17.2 Sun-Novo In Vitro Drug Release Testing Product Offered
11.17.3 Sun-Novo In Vitro Drug Release Testing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Sun-Novo Main Business Overview
11.17.5 Sun-Novo Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂